Evidence map›Paper›PMID 35726024›Full record

ArticleNature metabolism2022

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia.

Javier Garcia-Bermudez, Michael A Badgley, Sheela Prasad, Lou Baudrier, Yuyang Liu, Konnor La, Mariluz Soula, Robert T Williams, Norihiro Yamaguchi, Rosa F Hwang and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Javier Garcia-Bermudez *Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Michael A Badgley *Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.
Sheela Prasad *Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.
Lou BaudrierLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Yuyang LiuLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Konnor LaLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Mariluz SoulaLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Robert T WilliamsLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Norihiro YamaguchiLaboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Rosa F HwangDepartment of Breast Surgical Oncology, Division of Surgery, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
Laura J TaylorDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.
Elisa de StanchinaAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bety RostandyThe Proteomics Resource Center, The Rockefeller University, New York, NY, USA.
Hanan AlwaseemThe Proteomics Resource Center, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0002-4946-1436
Henrik MolinaThe Proteomics Resource Center, The Rockefeller University, New York, NY, USA.
Dafna Bar-SagiDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA. dafna.bar-sagi@nyulangone.org.
Kıvanç BirsoyLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA. kbirsoy@rockefeller.edu.ORCID http://orcid.org/0000-0002-7579-9895
Rockefeller University · USNew York University · USChildren's Medical Center · USMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptationR35CA210263 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAR-SAGI, DAFNA · 2016 to 2022
$6.6M
Targeting aspartate biosynthesis in pancreatic tumorsR00CA248838 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA BERMUDEZ, JAVIER · 2022 to 2024
$747k
Targeting aspartate biosynthesis in pancreatic tumorsK99CA248838 · NCI · ROCKEFELLER UNIVERSITY · PI GARCIA BERMUDEZ, JAVIER · 2020 to 2020
$128k
NCI NIH HHS K99 CA248838NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016087NCI NIH HHS R00 CA248838NCI NIH HHS R35 CA210263NCI NIH HHS T32 CA009161
6 · The paper itself

Abstract

Stress-adaptive mechanisms enable tumour cells to overcome metabolic constraints under nutrient and oxygen shortage. Aspartate is an endogenous metabolic limitation under hypoxic conditions, but the nature of the adaptive mechanisms that contribute to aspartate availability and hypoxic tumour growth are poorly understood. Here we identify GOT2-catalysed mitochondrial aspartate synthesis as an essential metabolic dependency for the proliferation of pancreatic tumour cells under hypoxic culture conditions. In contrast, GOT2-catalysed aspartate synthesis is dispensable for pancreatic tumour formation in vivo. The dependence of pancreatic tumour cells on aspartate synthesis is bypassed in part by a hypoxia-induced potentiation of extracellular protein scavenging via macropinocytosis. This effect is mutant KRAS dependent, and is mediated by hypoxia-inducible factor 1 (HIF1A) and its canonical target carbonic anhydrase-9 (CA9). Our findings reveal high plasticity of aspartate metabolism and define an adaptive regulatory role for macropinocytosis by which mutant KRAS tumours can overcome nutrient deprivation under hypoxic conditions.

Indexed as

Aspartic AcidPancreatic NeoplasmsCell Line, TumorHumansHypoxiaProto-Oncogene Proteins p21(ras)Aspartic AcidProto-Oncogene Proteins p21(ras)

Identifiers

PMID35726024
PMCPMC9678334
OpenAlexW4283172031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.